VIANEX S A has a total of 26 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, micro-structure and nano-technology and biotechnology are MORPHOGENESIS INC, ADVANTAGENE INC and KB BIOMED INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Australia | 4 | |
#3 | Canada | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Hungary | 2 | |
#6 | Republic of Korea | 2 | |
#7 | United States | 2 | |
#8 | China | 1 | |
#9 | United Kingdom | 1 | |
#10 | Hong Kong | 1 | |
#11 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Micro-structure and nano-technology | |
#3 | Biotechnology | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Nanostructure applications | |
#4 | Peptides | |
#5 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Nikolakakis Ioannis | 10 |
#2 | Apostolopoulos Vasso | 8 |
#3 | Matsoukas John | 8 |
#4 | Katsara Maria | 8 |
#5 | Tseveleki Vivian | 7 |
#6 | Probert Lesley | 7 |
#7 | Tselios Theodore | 6 |
#8 | Kagkadis Konstantinos Anastasi | 5 |
#9 | Tselios Theodoros | 2 |
#10 | Anastasi Kagkadis Konstantinos | 1 |
Publication | Filing date | Title |
---|---|---|
EP3556357A1 | Sustained release pyridostigmine compositions | |
EP3466409A1 | Self-emulsifying compositions of weakly ionizable or non-ionizable active pharmaceutical ingredients | |
AU2014200921A1 | Therapeutic vaccines | |
HUE037687T2 | Therapeutic vaccines | |
GB0127677D0 | Inclusion complex |